91 Results | Everything | Search

New Products

View New Products (1)

Product TypeClear Filters

Biochemicals (21)

Environmental Toxicology (1)

Natural Products (4)

Small Molecule Modulators (91)

Receptor Pharmacology (2)

Small Molecule Inhibitors (91)

Cytochrome P450 (2)

Methyltransferases (91)

Nucleic Acid Turnover/Signaling (1)

Phosphatases (1)

Reverse Transcriptases (1)

Research AreaClear Filters

Cancer (57)

Cardiovascular System (4)

Cell Biology (6)

Endocrinology & Metabolism (4)

Epigenetics, Transcription, & Translation (91)

Transcription Factors (2)

Writers (91)

DNA/RNA Methylation (1)

Histone Methylation (91)

Immunology & Inflammation (15)

Infectious Disease (8)

Neuroscience (4)

Oxidative Stress & Reactive Species (4)

Xenobiotic Metabolism (4)

ApplicationClear Filters

Fluorescence (2)

Displaying 1 - 25 of 91 Results

3-Deazaneplanocin A

An inhibitor of lysine methyltransferase EZH2

CAS No. 102052-95-9

Item No. 13828

Formulation: A crystalline solid

Purity: ≥97%

DZNep
NSC 617989

500 µg

$107

Add

1 mg

$193

Add

5 mg

$528

Add

10 mg

$762

Add

Chaetocin

Inhibitor of lys9-specific HMTs

CAS No. 28097-03-2

Item No. 13156

Formulation: A crystalline solid

Purity: ≥95%

500 µg

$97

Add

1 mg

$184

Add

5 mg

$630

Add

10 mg

$1,162

Add

GSK126

An EZH2 inhibitor

CAS No. 1346574-57-9

Item No. 15415

Formulation: A crystalline solid

Purity: ≥98%

GSK2816126

1 mg

$69

Add

5 mg

$132

Add

10 mg

$198

Add

EPZ015666

A bioavailable PRMT5 inhibitor

CAS No. 1616391-65-1

Item No. 17285

Formulation: A crystalline solid

Purity: ≥95%

GSK3235025

1 mg

$54

Add

5 mg

$238

Add

10 mg

$392

Add

25 mg

$783

Add

Urolithin A

A metabolite of ellagic acid with diverse biological activities

CAS No. 1143-70-0

Item No. 22607

Formulation: A crystalline solid

Purity: ≥98%

2',7-Dihydroxy-3,4-benzocoumarin
3,8-Dihydroxy Urolithin

1 mg

$25

Add

5 mg

$44

Add

10 mg

$75

Add

25 mg

$156

Add

EPZ6438

An EZH2 inhibitor

CAS No. 1403254-99-8

Item No. 16174

Formulation: A crystalline solid

Purity: ≥98%

Tazemetostat

1 mg

$36

Add

5 mg

$53

Add

10 mg

$71

Add

50 mg

$264

Add

BIX01294 (hydrochloride hydrate)

An inhibitor of G9a histone methyltransferase

CAS No. 1808255-64-2

Item No. 13124

Formulation: A crystalline solid

Purity: ≥98%

1 mg

$33

Add

5 mg

$125

Add

10 mg

$186

Add

50 mg

$614

Add

UNC1999

A selective, cell-permeable EZH2 inhibitor

CAS No. 1431612-23-5

Item No. 14621

Formulation: A crystalline solid

Purity: ≥98%

1 mg

$36

Add

5 mg

$77

Add

10 mg

$135

Add

50 mg

$502

Add

UNC0638

A G9a and GLP histone methyltransferase inhibitor

CAS No. 1255580-76-7

Item No. 10734

Formulation: A crystalline solid

Purity: ≥98%

1 mg

$53

Add

5 mg

$129

Add

10 mg

$231

Add

50 mg

$1,030

Add

EPZ5676

A highly potent DOT1L inhibitor

CAS No. 1380288-87-8

Item No. 16175

Formulation: A crystalline solid

Purity: ≥98%

1 mg

$49

Add

5 mg

$190

Add

10 mg

$306

Add

25 mg

$527

Add

GSK343

A selective, cell-permeable EZH2 inhibitor

CAS No. 1346704-33-3

Item No. 14094

Formulation: A crystalline solid

Purity: ≥95%

1 mg

$41

Add

5 mg

$128

Add

10 mg

$178

Add

25 mg

$341

Add

UNC0224

A potent inhibitor of G9a histone methyltransferase

CAS No. 1197196-48-7

Item No. 13631

Formulation: A crystalline solid

Purity: ≥98%

1 mg

$53

Add

5 mg

$129

Add

10 mg

$231

Add

50 mg

$1,030

Add

3-Deazaneplanocin A (hydrochloride)

An inhibitor of the lysine methyltransferase EZH2

CAS No. 120964-45-6

Item No. 11102

Formulation: A crystalline solid

Purity: ≥98%

2,3-DMMC

500 µg

$102

Add

1 mg

$192

Add

5 mg

$525

Add

UNC0642

A G9a histone methyltransferase inhibitor

CAS No. 1481677-78-4

Item No. 14604

Formulation: A crystalline solid

Purity: ≥95%

1 mg

$69

Add

5 mg

$198

Add

10 mg

$297

Add

SGC0946

A DOT1L inhibitor

CAS No. 1561178-17-3

Item No. 13967

Formulation: A crystalline solid

Purity: ≥98%

5 mg

$106

Add

10 mg

$201

Add

25 mg

$418

Add

50 mg

$783

Add

A-366

A potent inhibitor of G9a

CAS No. 1527503-11-2

Item No. 16081

Formulation: A crystalline solid

Purity: ≥98%

5 mg

$94

Add

10 mg

$174

Add

50 mg

$728

Add

MS023 (hydrochloride)

An inhibitor of type I PRMTs

CAS No. 2108631-19-0

Item No. 18361

Formulation: A crystalline solid

Purity: ≥95%

1 mg

$63

Add

5 mg

$274

Add

10 mg

$481

Add

25 mg

$1,053

Add

EPZ011989

An orally bioavailable EZH2 inhibitor

CAS No. 1598383-40-4

Item No. 19161

Formulation: A crystalline solid

Purity: ≥98%

500 µg

$132

Add

1 mg

$251

Add

5 mg

$1,048

Add

MM-102

An inhibitor of WDR5/MLL interactions

CAS No. 1417329-24-8

Item No. 17699

Formulation: A crystalline solid

Purity: ≥98%

1 mg

$36

Add

5 mg

$153

Add

10 mg

$253

Add

25 mg

$587

Add

UNC0379

A selective SET8 inhibitor

CAS No. 1620401-82-2

Item No. 16400

Formulation: A crystalline solid

Purity: ≥95%

5 mg

$61

Add

10 mg

$104

Add

25 mg

$242

Add

BVT 948

An inhibitor of protein tyrosine phosphatases

CAS No. 39674-97-0

Item No. 16615

Formulation: A crystalline solid

Purity: ≥95%

1 mg

$36

Add

5 mg

$105

Add

10 mg

$140

Add

50 mg

$304

Add

EED226

A potent and allosteric inhibitor of PRC2

CAS No. 2083627-02-3

Item No. 22031

Formulation: A solid

Purity: ≥99%

1 mg

$41

Add

5 mg

$178

Add

10 mg

$312

Add

25 mg

$631

Add

TP-064

A potent inhibitor of PRMT4

CAS No. 2080306-20-1

Item No. 20256

Formulation: A crystalline solid

Purity: ≥98%

1 mg

$36

Add

5 mg

$128

Add

10 mg

$169

Add

25 mg

$378

Add

(R)-PFI-2 (hydrochloride)

A SET7/9 inhibitor

CAS No. 1627607-87-7

Item No. 14678

Formulation: A crystalline solid

Purity: ≥95%

(-)-PFI-2

1 mg

$28

Add

5 mg

$83

Add

10 mg

$152

Add

25 mg

$275

Add

EZM2302

A PRMT4 inhibitor

CAS No. 1628830-21-6

Item No. 29954

Formulation: A solid

Purity: ≥98%

GSK3359088

1 mg

$75

Add

5 mg

$351

Add

10 mg

$662

Add

Displaying 1 - 25 of 91 Results

Cart Subtotal:$0

New Products

Product TypeClear Filters

Research AreaClear Filters

ApplicationClear Filters

Formulation: A crystalline solid

Purity: ≥97%

Formulation: A crystalline solid

Purity: ≥95%

Formulation: A crystalline solid

Purity: ≥98%

Formulation: A crystalline solid

Purity: ≥95%

Formulation: A crystalline solid

Purity: ≥98%

Formulation: A crystalline solid

Purity: ≥98%

Formulation: A crystalline solid

Purity: ≥98%

Formulation: A crystalline solid

Purity: ≥98%

Formulation: A crystalline solid

Purity: ≥98%

Formulation: A crystalline solid

Purity: ≥98%

Formulation: A crystalline solid

Purity: ≥95%

Formulation: A crystalline solid

Purity: ≥98%

Formulation: A crystalline solid

Purity: ≥98%

Formulation: A crystalline solid

Purity: ≥95%

Formulation: A crystalline solid

Purity: ≥98%

Formulation: A crystalline solid

Purity: ≥98%

Formulation: A crystalline solid

Purity: ≥95%

Formulation: A crystalline solid

Purity: ≥98%

Formulation: A crystalline solid

Purity: ≥98%

Formulation: A crystalline solid

Purity: ≥95%

Formulation: A crystalline solid

Purity: ≥95%

Formulation: A solid

Purity: ≥99%

Formulation: A crystalline solid

Purity: ≥98%

Formulation: A crystalline solid

Purity: ≥95%

Formulation: A solid

Purity: ≥98%